ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan · Delayed Price · Currency is TWD 19.00
+0.05 (0.26%)
Sep 8, 2026, 12:13 PM CST
ShareHope Medicine Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,496 | 4,358 | 4,326 | 3,873 | 4,137 | 3,850 |
Revenue Growth | 2.52% | 0.74% | 11.68% | -6.38% | 7.46% | -6.07% |
Gross Profit Gross Profit Growth | 717.24 | 709.01 | 714.4 | 726.38 | 983.91 | 833.96 |
Operating Income Operating Income Growth | 197.97 | 158.56 | 42.61 | 94.69 | 329.38 | 254.26 |
Net Income Net Income Growth | 162.17 | 141.73 | 200.1 | 124.56 | 293.95 | 232.66 |
Earnings Per Share EPS Growth | 1.18 | 1.03 | 1.45 | 0.90 | 2.12 | 1.68 |
EPS Growth | -0.60% | -28.99% | 60.26% | -57.41% | 26.73% | -4.75% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Circulation Business Development Medical Circulation Business Development Growth | 3,753 | 3,515 | 3,421 | 2,879 | 2,870 | 2,790 |
Integrated Management Division Integrated Management Division Growth | 655.55 | 628.6 | 643 | 646.68 | 905.8 | 631.64 |
Technological Material Business Segment Technological Material Business Segment Growth | 123.07 | 129.69 | 109.8 | 134.77 | 190.5 | 251.25 |
Hospital Business Segment Hospital Business Segment Growth | 125.1 | 124.47 | 96.23 | 132.02 | 134.14 | 143.87 |
Other Department Other Department Growth | 247.39 | 260.67 | 293.13 | 288.06 | 225.74 | 283.07 |
Adjustment and Elimination Adjustment and Elimination Growth | -407.88 | -300.26 | -237.39 | -206.71 | -188.61 | -250.03 |
Total Total Growth | 4,496 | 4,358 | 4,326 | 3,873 | 4,137 | 3,850 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,515 | 1,557 | 1,470 | 1,393 | 1,546 | 1,567 |
Total Debt Total Debt Growth | 1,767 | 1,792 | 1,987 | 2,180 | 2,006 | 1,209 |
Net Cash (Debt) Net Cash Growth | -251.62 | -235.07 | -517.02 | -786.54 | -460.08 | 358.67 |
Net Cash Growth | - | - | - | - | - | -52.09% |
Net Cash Per Share Net Cash Per Share Growth | -1.82 | -1.70 | -3.74 | -5.69 | -3.32 | 2.58 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 407.55 | 364.13 | 266.68 | 257.13 | 642.47 | 360.1 |
Capital Expenditures CapEx Growth | -73.99 | -123.98 | -83.07 | -250.31 | -1,266 | -137.51 |
Free Cash Flow Free Cash Flow Growth | 333.56 | 240.15 | 183.6 | 6.83 | -623.51 | 222.59 |
Free Cash Flow Growth | 143.17% | 30.80% | 2589.38% | - | - | -38.14% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.95% | 16.27% | 16.52% | 18.75% | 23.78% | 21.66% |
Operating Margin | 4.40% | 3.64% | 0.98% | 2.44% | 7.96% | 6.60% |
Pretax Margin | 4.42% | 3.45% | 4.02% | 2.81% | 8.22% | 6.95% |
Profit Margin | 3.61% | 3.25% | 4.63% | 3.22% | 7.11% | 6.04% |
FCF Margin | 7.42% | 5.51% | 4.24% | 0.18% | -15.07% | 5.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.600 | - | 0.500 | 0.366 | 0.436 | 0.415 |
Dividend Per Share Growth | 20.00% | - | 36.50% | -16.01% | 5.01% | 5.01% |
Dividend Yield | 3.16% | - | 1.91% | 1.29% | 1.60% | 2.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.08 | 22.68 | 18.97 | 33.29 | 13.80 | 13.27 |
Forward PE | - | 17.88 | 17.88 | 17.88 | 17.88 | 17.88 |
P/FCF Ratio | 7.82 | 13.38 | 20.67 | 607.42 | - | 13.87 |
PS Ratio | 0.58 | 0.74 | 0.88 | 1.07 | 0.98 | 0.80 |